Mepolizumab in Episodic Angioedema With Eosinophilia

Conditions:   Eosinophilia;   Angioedema Intervention:   Biological: Nucala (mepolizumab) Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials